IL17A and neoplasm: As shown in Fig. 5B, tumor-bearing mice vaccinated with PELC-adjuvanted OVA elicited a high number of both IFN-γ+ and IL-17+ cells at tumor-adjacent counterparts compared to non-adjuvanted OVA.